Join more than 1.500 of your peers to stay up to date with the latest in thrombosis.
Sign up now!
The information below is based on European or United Kingdom Summaries of Product Characteristics – approved uses and recommendations for drugs vary by region/country
This table is intended as a quick reference guide only and is not an exhaustive list; refer to local prescribing information for full drug information and use clinical judgement before prescribing
When to use a reduced NOAC dose
Patients receiving anticoagulation with a NOAC should receive a reduced dose in certain clinical situations
© Bayer AG, 2017 | Approval number: PP-XAR-ALL-1742-1
The information in this table is taken from the respective Summary of Product Characteristics for the therapies shown, available at the links provided in the table.